PN ship holds free medical camp in Senegal

PNS ALAMGIR visits Senegal’s Port of Dakar, sets up free medical camp

APP December 06, 2021


Pakistan Navy Ship (PNS) Alamgir Sunday visited Dakar, Senegal and established free medical camp as a goodwill gesture.

Upon arrival, Pakistan Navy Ship was received by the officials from Ministry of Health of Senegal, naval officials and Pakistan defence attaché, said a Pakistan Navy statement.

During the port visit, mission commander along with commanding officer of PNS Alamgir called on minister of defence of Senegal, chief of naval staff of Senegal and chief of air staff of Senegal. During the interactions, matters of mutual interests were discussed and enhancement of bilateral ties in all spheres was reaffirmed.

Taking the opportunity, the mission commander conveyed good wishes of chief of the naval staff for the people of Senegal in general and the Senegal Navy in particular.

As a goodwill gesture and to extend humanitarian assistance, free medical camp was established in the city of Dakar by Pakistan Navy. A specialised team of Pakistan Navy doctors and paramedics provided medical treatment and medicines to over 2,000 patients.

Read: PM lauds ‘hero’ who tried to rescue Priyantha

The implementation of Covid-19 SOPs was ensured during the medical camp. Establishment of free medical camp by Pakistan Navy was widely appreciated by the local populace.

Upon completion of port visit, PNS Alamgir conducted bilateral passage exercise with Senegal navy ship to enhance interoperability between the two navies.

The ongoing deployment is aimed at fostering friendly ties with African countries, enhancing naval collaboration, extending humanitarian assistance and developing interoperability with the host navy.

The visit of PNS Alamgir to Senegal provided an opportunity for both countries to further enhance the existing close diplomatic ties and cordial relations.


Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ


Most Read